Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, appointed four new hires to its leadership team.
The San Diego-based pharmaceutical company Prometheus Laboratories launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab.
Allergan and SonarMD partnered to develop clinical decision support and patient engagement tools to diagnose and manage patients with a form of irritable bowel syndrome.
A study presented at United European Gastroenterology Week found that MOTUS GI‘s Pure-Vu System effectively cleans poorly-prepared colons during colonoscopy procedure, so that colorectal cancer screening can take place.
Takeda Pharmaceuticals presented data on the use of vedolizumab for treating ulcerative colitis and Crohn’s disease at the American College of Gastroenterology Annual Scientific Meeting.
More articles on gastroenterology and endoscopy:
Pure-Vu System effective for intra-procedural colon cleaning: 3 data insights
Obesity, liver cancer linked in prospective study: 3 insights
ACG names Dr. Carol Burke president: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
